Loading
Latest filing published 03 Mar 2026 for FibroBiologics, Inc., €25k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Jason Davis across 3 companies, led by Hyperdynamics Corp, FibroBiologics, Inc. and Particle Drilling Technologies Inc/NV. In total, 5 filings cover trades dated from 17 April 2009 to 2 March 2026.
Every open-market trade on record is a purchase: 2 purchases worth €68k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants. In 2026 alone, the filings show 1 purchase and no sales.
The record was last updated on 3 March 2026 with an open-market purchase (€25k) in FibroBiologics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations